Cardio Diagnostics Holdings, Inc.
CDIO
$4.66
-$0.1077-2.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -94.34% | -15.09% | -34.00% | 364.71% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -94.34% | -15.09% | -34.00% | 364.71% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -94.34% | -15.09% | -34.00% | 364.71% | -- |
| SG&A Expenses | -61.91% | -1.64% | -0.37% | -49.63% | 158.01% |
| Depreciation & Amortization | 845.83% | 10.42% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -60.91% | -1.71% | -2.66% | -49.50% | 145.08% |
| Operating Income | 60.78% | 1.66% | 2.44% | 49.77% | -144.14% |
| Income Before Tax | 60.73% | -9.39% | 26.90% | 67.98% | -303.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 60.73% | -9.39% | 26.90% | 67.98% | -303.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.73% | -9.39% | 26.90% | 67.98% | -303.22% |
| EBIT | 60.78% | 1.66% | 2.44% | 49.77% | -144.14% |
| EBITDA | 63.55% | 3.26% | 5.52% | 52.86% | -143.17% |
| EPS Basic | 83.64% | 47.22% | 64.40% | 85.49% | -82.64% |
| Normalized Basic EPS | 83.64% | 60.02% | 66.37% | 84.05% | -82.64% |
| EPS Diluted | 83.64% | 47.22% | 64.40% | 85.49% | -82.64% |
| Normalized Diluted EPS | 83.64% | 60.02% | 66.37% | 84.05% | -82.64% |
| Average Basic Shares Outstanding | 139.98% | 107.27% | 105.34% | 120.74% | 120.80% |
| Average Diluted Shares Outstanding | 139.98% | 107.27% | 105.34% | 120.74% | 120.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |